For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.
Adverse Events Module path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Groups
Study -> Results Section -> Adverse Events Module -> Serious Events
Study -> Results Section -> Adverse Events Module -> Other Events
| Title | Description | Deaths # Affected | Deaths # At Risk | Serious # Affected | Serious # At Risk | Other # Affected | Other # At Risk | View |
|---|---|---|---|---|---|---|---|---|
| Seletracetam | Escalating doses of 10, 20, 40 and 80 mg b.i.d. (twice daily) (total daily doses of 20 - 160 mg) were to be administered orally as capsules. | None | None | 0 | 31 | 27 | 31 | View |
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| Irritability | None | General disorders | MedDRA | View |
| Pyrexia | None | General disorders | MedDRA | View |
| Tenderness | None | General disorders | MedDRA | View |
| Multiple allergies | None | Immune system disorders | MedDRA | View |
| Ear infection | None | Infections and infestations | MedDRA | View |
| Nasopharyngitis | None | Infections and infestations | MedDRA | View |
| Rhinitis | None | Infections and infestations | MedDRA | View |
| Upper respiratory tract infection | None | Infections and infestations | MedDRA | View |
| Urinary tract infection | None | Infections and infestations | MedDRA | View |
| Vaginal infection | None | Infections and infestations | MedDRA | View |
| Viral infection | None | Infections and infestations | MedDRA | View |
| Anticonvulsant toxicity | None | Injury, poisoning and procedural complications | MedDRA | View |
| Arthropod sting | None | Injury, poisoning and procedural complications | MedDRA | View |
| Chest injury | None | Injury, poisoning and procedural complications | MedDRA | View |
| Contusion | None | Injury, poisoning and procedural complications | MedDRA | View |
| Fall | None | Injury, poisoning and procedural complications | MedDRA | View |
| Scratch | None | Injury, poisoning and procedural complications | MedDRA | View |
| Tongue injury | None | Injury, poisoning and procedural complications | MedDRA | View |
| Tooth injury | None | Injury, poisoning and procedural complications | MedDRA | View |
| Alanine aminotransferase increased | None | Investigations | MedDRA | View |
| Aspartate aminotransferase increased | None | Investigations | MedDRA | View |
| Blood creatine phosphokinase increased | None | Investigations | MedDRA | View |
| Blood thyroid stimulating hormone increased | None | Investigations | MedDRA | View |
| Gamma-glutamyltransferase increased | None | Investigations | MedDRA | View |
| Liver function test abnormal | None | Investigations | MedDRA | View |
| Platelet count decreased | None | Investigations | MedDRA | View |
| Positive Rombergism | None | Investigations | MedDRA | View |
| Red blood cell morphology abnormal | None | Investigations | MedDRA | View |
| Urine analysis abnormal | None | Investigations | MedDRA | View |
| Anorexia | None | Metabolism and nutrition disorders | MedDRA | View |
| Decreased appetite | None | Metabolism and nutrition disorders | MedDRA | View |
| Hyponatraemia | None | Metabolism and nutrition disorders | MedDRA | View |
| Arthralgia | None | Musculoskeletal and connective tissue disorders | MedDRA | View |
| Back pain | None | Musculoskeletal and connective tissue disorders | MedDRA | View |
| Convulsion | None | Nervous system disorders | MedDRA | View |
| Coordination abnormal | None | Nervous system disorders | MedDRA | View |
| Dizziness | None | Nervous system disorders | MedDRA | View |
| Headache | None | Nervous system disorders | MedDRA | View |
| Hypersomnia | None | Nervous system disorders | MedDRA | View |
| Migraine | None | Nervous system disorders | MedDRA | View |
| Nystagmus | None | Nervous system disorders | MedDRA | View |
| Sensory disturbance | None | Nervous system disorders | MedDRA | View |
| Sinus headache | None | Nervous system disorders | MedDRA | View |
| Somnolence | None | Nervous system disorders | MedDRA | View |
| Tremor | None | Nervous system disorders | MedDRA | View |
| Anxiety | None | Psychiatric disorders | MedDRA | View |
| Confusional state | None | Psychiatric disorders | MedDRA | View |
| Crying | None | Psychiatric disorders | MedDRA | View |
| Depressed mood | None | Psychiatric disorders | MedDRA | View |
| Depression | None | Psychiatric disorders | MedDRA | View |
| Emotional disorder | None | Psychiatric disorders | MedDRA | View |
| Insomnia | None | Psychiatric disorders | MedDRA | View |
| Nervousness | None | Psychiatric disorders | MedDRA | View |
| Paranoia | None | Psychiatric disorders | MedDRA | View |
| Nasal congestion | None | Respiratory, thoracic and mediastinal disorders | MedDRA | View |
| Respiratory tract congestion | None | Respiratory, thoracic and mediastinal disorders | MedDRA | View |
| Sinus congestion | None | Respiratory, thoracic and mediastinal disorders | MedDRA | View |
| Blister | None | Skin and subcutaneous tissue disorders | MedDRA | View |
| Dry skin | None | Skin and subcutaneous tissue disorders | MedDRA | View |
| Rash maculo-papular | None | Skin and subcutaneous tissue disorders | MedDRA | View |
| Poor venous access | None | Vascular disorders | MedDRA | View |
| Fatigue | None | General disorders | MedDRA | View |
| Gait disturbance | None | General disorders | MedDRA | View |
| Sinus bradycardia | None | Cardiac disorders | MedDRA | View |
| Motion sickness | None | Ear and labyrinth disorders | MedDRA | View |
| Tinnitus | None | Ear and labyrinth disorders | MedDRA | View |
| Eye irritation | None | Eye disorders | MedDRA | View |
| Abdominal pain lower | None | Gastrointestinal disorders | MedDRA | View |
| Abdominal tenderness | None | Gastrointestinal disorders | MedDRA | View |
| Constipation | None | Gastrointestinal disorders | MedDRA | View |
| Diarrhoea | None | Gastrointestinal disorders | MedDRA | View |
| Gastrooesophageal reflux disease | None | Gastrointestinal disorders | MedDRA | View |
| Nausea | None | Gastrointestinal disorders | MedDRA | View |
| Stomach discomfort | None | Gastrointestinal disorders | MedDRA | View |
| Asthenia | None | General disorders | MedDRA | View |
| Energy increased | None | General disorders | MedDRA | View |